
Wolfgang C. Winkelmayer MD MPH, ScD
Professor and Chief, Section of Nephrology, Baylor College of Medicine
Join to view full profile
1504 Taub LoopHouston, TX 77030
Phone+1 713-873-8890
Dr. Winkelmayer is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Mass General Brigham/Brigham and Women's Hospital/Massachusetts General HospitalFellowship, Nephrology, 2007 - 2009
Harvard T.H. Chan School of Public HealthSc.D., Health Policy and Management, 1999 - 2001
Harvard T.H. Chan School of Public HealthM.P.H., Health Care Management, 1998 - 1999
University of Vienna Faculty of MedicineClass of 1990, M.D.
Certifications & Licensure
TX State Medical License 2015 - 2027
CA State Medical License 2010 - 2023
Awards, Honors, & Recognition
- Fellow (ASNF) American Society of Nephrology
Publications & Presentations
PubMed
- Initiation of Apixaban Versus Warfarin in Patients With Kidney Failure on Hemodialysis With Newly Diagnosed Atrial Fibrillation: A Target Trial Emulation.Wolfgang C Winkelmayer, Maria E Montez-Rath, Mingyue He, Kevin F Erickson, L Parker Gregg
American Journal of Kidney Diseases. 2026-10-21 - Authors' Reply: β-Blockers in Hemodialysis Outcome Trial.Ali Etemadi, Wolfgang C Winkelmayer, Maria E Montez-Rath, Tara I Chang
Journal of the American Society of Nephrology. 2026-10-12 - Evolution of Stakeholder Involvement and Scope of Research Priority-Setting Studies in Kidney Disease: A Systematic Review.Dale Coghlan, Allison Jauré, Jonathan C Craig, Shilpanjali Jesudason, Chandana Guha
American Journal of Kidney Diseases. 2026-10-05
Journal Articles
- Nephrology and COVID-19Wolfgang C Winkelmayer, Pascale Khairallah, David M Charytan, JAMA
- Dialysis Modality and Incident Atrial Fibrillation in Older Patients with ESRDJose J Perez, Medha Airy, Sankar D Navaneethan, Wolfgang C Winkelmayer, American Journal of Kidney Diseases
- Health Insurance in the First 3 Months of Hemodialysis and Early Vascular AccessMatthew W Mell, Wolfgang C Winkelmayer, Journal of the American Society of Nephrology
Authored Content
- Did Medicaid Expansion Reduce Mortality Among Patients Initiating Dialysis for Irreversible Kidney Failure?October 2018
- Did Medicaid Expansion Reduce Mortality Among Patients Initiating Dialysis for Irreversible Kidney Failure?October 2018
- Mapping Progress in Reducing Cardiovascular Risk with Kidney DiseaseAugust 2018
Press Mentions
MERCURI-2: Dapagliflozin Before Cardiac Surgery Lowers Postoperative AKI RiskAugust 11th, 2026
Novel Anticoagulant Flops for Staving off Graft Thrombosis in Dialysis PatientsJune 6th, 2025
KDIGO Launches Guideline Fellowship ProgramNovember 1st, 2024
Grant Support
- The Atrial Fibrillation-Factor Identification to Risk Modification Study in CKD/ESRDBAYLOR COLLEGE OF MEDICINE2012–2024
- Comparative Effectiveness And Safety Of Newer Agents For Anemia Treatment In HDNational Institute Of Diabetes And Digestive And Kidney Diseases2011
- Warfarin Use In ESRD Patients With Atrial Fibrillation: Risks, Benefits, BehaviorNational Institute Of Diabetes And Digestive And Kidney Diseases2010
- Warfarin Use In ESRD Patients With Atrial Fibrillation: Risks, Benefits, BehaviorNational Institute Of Diabetes And Digestive And Kidney Diseases2009
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: